|
US7091181B2
(en)
|
1994-12-12 |
2006-08-15 |
Omeros Corporation |
Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
|
|
US6608060B1
(en)
|
1996-12-18 |
2003-08-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
WO1999019471A1
(en)
|
1997-10-16 |
1999-04-22 |
Board Of Regents, The University Of Texas System |
Models and treatments for cardiac hypertrophy in relation with nf-at3 function
|
|
WO1999032121A1
(en)
|
1997-12-19 |
1999-07-01 |
Smithkline Beecham Corporation |
Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
|
|
MY132496A
(en)
*
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
|
WO1999061039A2
(en)
*
|
1998-05-22 |
1999-12-02 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel composition for modulating ischemic cell death
|
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
EP1277740A1
(en)
*
|
1998-06-12 |
2003-01-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
JP2002517486A
(ja)
|
1998-06-12 |
2002-06-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｐ３８のインヒビター
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
WO2000017175A1
(en)
*
|
1998-09-18 |
2000-03-30 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF p38
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
AU1127700A
(en)
*
|
1998-10-20 |
2000-05-08 |
Omeros Medical Systems, Inc. |
Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
|
|
WO2000025791A1
(en)
|
1998-11-04 |
2000-05-11 |
Smithkline Beecham Corporation |
Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
|
|
UA73492C2
(en)
*
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
|
NZ528846A
(en)
|
1999-03-12 |
2005-05-27 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
|
WO2000055152A1
(en)
|
1999-03-12 |
2000-09-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
JP2000281588A
(ja)
*
|
1999-03-30 |
2000-10-10 |
Sankyo Co Ltd |
ガンの予防又は治療薬及びそのスクリーニング方法
|
|
WO2001001986A1
(en)
*
|
1999-07-02 |
2001-01-11 |
Lipton Stuart A |
Method of reducing neuronal injury or apoptosis
|
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
|
DE60033307T2
(de)
*
|
1999-10-21 |
2007-07-12 |
F. Hoffmann-La Roche Ag |
Heteroalkylamino-substituierte bicyclische stickstoffheterocyclen als p38-proteinkinase-inhibitoren
|
|
KR100537241B1
(ko)
*
|
1999-10-21 |
2005-12-19 |
에프. 호프만-라 로슈 아게 |
Ｐ38 단백질 키나제의 억제제로서의 알킬아미노 치환된이중고리 질소 헤테로고리 화합물
|
|
EP1233951B1
(en)
*
|
1999-11-23 |
2005-06-01 |
SmithKline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
|
|
ATE305787T1
(de)
|
1999-11-23 |
2005-10-15 |
Smithkline Beecham Corp |
3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
|
|
US6759410B1
(en)
|
1999-11-23 |
2004-07-06 |
Smithline Beecham Corporation |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
|
CA2403828A1
(en)
*
|
2000-03-22 |
2001-09-27 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
JP4993838B2
(ja)
*
|
2000-08-11 |
2012-08-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｐ３８のインヒビターとしてのピリジン誘導体
|
|
PE20020506A1
(es)
*
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
ATE521353T1
(de)
|
2000-10-23 |
2011-09-15 |
Glaxosmithkline Llc |
Neues trisubstitutiertes 8h-pyridoä2,3- düpyrimidin-7-onderivat zur behandlung von durch csbp/p38kinase vermittelten krankheiten
|
|
US6670357B2
(en)
*
|
2000-11-17 |
2003-12-30 |
Bristol-Myers Squibb Company |
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
|
|
US6867300B2
(en)
*
|
2000-11-17 |
2005-03-15 |
Bristol-Myers Squibb Company |
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
|
|
EP1345603A4
(en)
*
|
2000-12-20 |
2004-09-08 |
Merck & Co Inc |
(HALO-BENZO-CARBONYL) HETEROCYCLO-CONDENSED PHENYL-P38-KINASE INHIBITING AGENTS
|
|
DE60206363T2
(de)
*
|
2001-02-12 |
2006-07-06 |
F. Hoffmann-La Roche Ag |
6-substituierte pyridopyrimidine
|
|
GB0112348D0
(en)
*
|
2001-05-19 |
2001-07-11 |
Smithkline Beecham Plc |
Compounds
|
|
GB2375771A
(en)
*
|
2001-05-24 |
2002-11-27 |
Univ Leeds |
Decellularisation of tissue implant material
|
|
ATE415162T1
(de)
|
2001-06-11 |
2008-12-15 |
Vertex Pharma |
Isochinolin-inhibitoren von p38
|
|
US6794265B2
(en)
|
2001-08-02 |
2004-09-21 |
Ultradots, Inc. |
Methods of forming quantum dots of Group IV semiconductor materials
|
|
US7005669B1
(en)
|
2001-08-02 |
2006-02-28 |
Ultradots, Inc. |
Quantum dots, nanocomposite materials with quantum dots, devices with quantum dots, and related fabrication methods
|
|
US6819845B2
(en)
|
2001-08-02 |
2004-11-16 |
Ultradots, Inc. |
Optical devices with engineered nonlinear nanocomposite materials
|
|
US20030066998A1
(en)
|
2001-08-02 |
2003-04-10 |
Lee Howard Wing Hoon |
Quantum dots of Group IV semiconductor materials
|
|
US6710366B1
(en)
|
2001-08-02 |
2004-03-23 |
Ultradots, Inc. |
Nanocomposite materials with engineered properties
|
|
GB0124932D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124934D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124941D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124939D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124931D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124933D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124938D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO2003060102A2
(en)
*
|
2002-01-11 |
2003-07-24 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of jnk-inhibitor complexes and binding pockets thereof
|
|
AU2003209321A1
(en)
*
|
2002-01-18 |
2003-07-30 |
Pharmacia Corporation |
Substituted pyridazinones as inhibitors of p38
|
|
EP2258687B1
(en)
|
2002-02-12 |
2012-12-26 |
Glaxosmithkline LLC |
Nicotinamide derivates useful as P38 inhibitors
|
|
ATE386030T1
(de)
|
2002-02-25 |
2008-03-15 |
Boehringer Ingelheim Pharma |
1,4-disubstituierte benzokondensierte cycloalkyl- harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen
|
|
EP1494664A2
(en)
*
|
2002-04-18 |
2005-01-12 |
Pharmacia Corporation |
Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
|
|
KR20040103972A
(ko)
|
2002-04-19 |
2004-12-09 |
스미스클라인 비참 코포레이션 |
신규 화합물
|
|
KR101025675B1
(ko)
|
2002-04-23 |
2011-03-30 |
브리스톨-마이어스 스큅 컴퍼니 |
키나제 억제제로서 유용한 피롤로-트리아진 아닐린 화합물
|
|
US7388009B2
(en)
*
|
2002-04-23 |
2008-06-17 |
Bristol-Myers Squibb Company |
Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors
|
|
JP2005529890A
(ja)
*
|
2002-04-23 |
2005-10-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用なアリールケトンピロロトリアジン化合物
|
|
TW200400034A
(en)
*
|
2002-05-20 |
2004-01-01 |
Bristol Myers Squibb Co |
Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
|
|
DE60317198T2
(de)
*
|
2002-05-23 |
2008-12-04 |
Cytopia Research Pty. Ltd., Richmond |
Proteinkinaseinhibitoren
|
|
DE60310730T2
(de)
|
2002-07-09 |
2007-05-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
JP5204947B2
(ja)
|
2002-11-27 |
2013-06-05 |
ディーエムアイ バイオサイエンシズ インコーポレイテッド |
リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
|
|
GB0308201D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308186D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
DK1618092T3
(da)
*
|
2003-05-01 |
2011-01-31 |
Bristol Myers Squibb Co |
Aryl-substituerede pyrazol-amidforbindelser, der er anvendelige som kinasehæmmere
|
|
MXPA05012377A
(es)
|
2003-05-15 |
2006-05-25 |
Arqule Inc |
Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38.
|
|
US7652044B2
(en)
*
|
2003-06-03 |
2010-01-26 |
Novartis A.G. |
P-38 inhibitors
|
|
KR101120857B1
(ko)
|
2003-06-26 |
2012-04-12 |
노파르티스 아게 |
5원의 헤테로사이클-기재 ｐ38 키나제 억제제
|
|
WO2005007632A1
(en)
*
|
2003-07-18 |
2005-01-27 |
Pharmacia Corporation |
Substituted pyridazinones as inhibitors of p38
|
|
ATE482205T1
(de)
|
2003-07-25 |
2010-10-15 |
Novartis Ag |
P-38-kinasehemmer
|
|
GB0318814D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
US7419978B2
(en)
*
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
|
CA2545422C
(en)
|
2003-12-03 |
2015-06-02 |
Cytopia Research Pty Ltd |
Tubulin inhibitors
|
|
GB0402143D0
(en)
*
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
WO2006010082A1
(en)
|
2004-07-08 |
2006-01-26 |
Arqule, Inc. |
1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
|
|
US7504521B2
(en)
*
|
2004-08-05 |
2009-03-17 |
Bristol-Myers Squibb Co. |
Methods for the preparation of pyrrolotriazine compounds
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
US7148348B2
(en)
|
2004-08-12 |
2006-12-12 |
Bristol-Myers Squibb Company |
Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
|
|
WO2006021848A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Ranbaxy Laboratories Limited |
Anti-inflammatory agents
|
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
|
JP2008517064A
(ja)
|
2004-10-19 |
2008-05-22 |
アークル インコーポレイテッド |
Ｐ３８ｍａｐキナーゼのイミダゾオキサゾールおよびイミダゾチアゾール阻害剤の合成
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
US20060178388A1
(en)
*
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
UY29439A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
WO2006110298A2
(en)
|
2005-03-25 |
2006-10-19 |
Glaxo Group Limited |
8-alkyl/aryl-4-aryl-2-n- (alkylamino)-n'-substituted-n'-cyanoguanidino-8h-pyrido[2,3-d]pyrimidin-7-one compounds and use thereof
|
|
UY29440A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
EP1865959A2
(en)
|
2005-03-25 |
2007-12-19 |
Glaxo Group Limited |
Process for preparing pyridoý2,3-d¨pyrimidin-7-one and 3,4-dihydropyrimidoý4,5-d¨pyrimidin-2(1h)-one derivatives
|
|
US20060235020A1
(en)
*
|
2005-04-18 |
2006-10-19 |
Soojin Kim |
Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
|
|
GB0512429D0
(en)
*
|
2005-06-17 |
2005-07-27 |
Smithkline Beecham Corp |
Novel compound
|
|
US7473784B2
(en)
*
|
2005-08-01 |
2009-01-06 |
Bristol-Myers Squibb Company |
Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
|
|
JP5113751B2
(ja)
*
|
2005-08-12 |
2013-01-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ｐ３８キナーゼ阻害剤として有用な二環性複素環化合物
|
|
EP1953148B1
(en)
|
2005-10-28 |
2012-02-29 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof
|
|
CN101395158A
(zh)
*
|
2006-03-07 |
2009-03-25 |
百时美施贵宝公司 |
可作为激酶抑制剂的吡咯并三嗪苯胺前体药物化合物
|
|
JP2010508288A
(ja)
*
|
2006-10-27 |
2010-03-18 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用なヘテロサイクリックアミド化合物
|
|
US7943617B2
(en)
|
2006-11-27 |
2011-05-17 |
Bristol-Myers Squibb Company |
Heterobicyclic compounds useful as kinase inhibitors
|
|
CA2681420A1
(en)
*
|
2007-03-20 |
2008-09-25 |
Cadila Pharmaceuticals Limited |
P38 inhibitors
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
EP2108641A1
(en)
*
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
|
JP2011525184A
(ja)
*
|
2008-06-20 |
2011-09-15 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用なトリアゾロピリジン化合物
|
|
US8338604B2
(en)
|
2008-06-20 |
2012-12-25 |
Bristol-Myers Squibb Company |
Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
|
|
WO2010038428A1
(ja)
*
|
2008-09-30 |
2010-04-08 |
武田薬品工業株式会社 |
タキサン系抗がん剤の置き換え薬
|
|
MX2011008276A
(es)
|
2009-02-06 |
2011-12-14 |
Elan Pharm Inc |
Inhibidores de quinasa jun n-terminal.
|
|
GB0902648D0
(en)
|
2009-02-17 |
2009-04-01 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
GB0908317D0
(en)
*
|
2009-05-14 |
2009-06-24 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
WO2012031057A1
(en)
|
2010-09-01 |
2012-03-08 |
Bristol-Myers Squibb Company |
Bms- 582949 for the treatment of resistant rheumatic disease
|
|
CA2835707C
(en)
*
|
2011-05-09 |
2019-02-26 |
Eip Pharma, Llc |
Compositions and methods for treating alzheimer's disease
|
|
EP2799537B1
(en)
|
2011-12-28 |
2021-09-22 |
Kyoto Prefectural Public University Corporation |
Normalization of culture of corneal endothelial cells
|
|
CN103772392A
(zh)
*
|
2012-10-23 |
2014-05-07 |
杨子娇 |
一类治疗房角狭窄的化合物及其用途
|
|
WO2015072580A1
(ja)
|
2013-11-14 |
2015-05-21 |
学校法人同志社 |
細胞増殖促進または細胞障害抑制による角膜内皮治療薬
|
|
CN106659723A
(zh)
|
2014-07-09 |
2017-05-10 |
爱普制药有限责任公司 |
用于治疗神经病症的方法
|
|
WO2017075274A1
(en)
|
2015-10-27 |
2017-05-04 |
Children's Hospital Medical Center |
Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and/or genetic manipulation
|
|
WO2017151409A1
(en)
|
2016-02-29 |
2017-09-08 |
University Of Florida Research Foundation, Incorporated |
Chemotherapeutic methods
|
|
WO2019056003A1
(en)
|
2017-09-18 |
2019-03-21 |
Eip Pharma, Llc |
CO-CRYSTALS FROM NEFLAMAPIMOD (VX -745)
|
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
|
WO2019071147A1
(en)
|
2017-10-05 |
2019-04-11 |
Fulcrum Therapeutics, Inc. |
INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD
|
|
BR112020018094A2
(pt)
|
2018-03-08 |
2020-12-22 |
Incyte Corporation |
Compostos de aminopirazina diol como inibidores de pi3k-¿
|
|
US11046658B2
(en)
|
2018-07-02 |
2021-06-29 |
Incyte Corporation |
Aminopyrazine derivatives as PI3K-γ inhibitors
|
|
WO2020108659A1
(zh)
|
2018-11-30 |
2020-06-04 |
上海医药集团股份有限公司 |
含氮杂环类化合物及其组合物、制备方法和应用
|